Ruthenium–arene complexes with Bis(pyrazol-1-yl)methane ligands: Structural characterization, DFT investigation, and preliminary cytotoxicity studies
Authors:
- Amos K. KanyoraAKAmos K. Kanyora
- Thato T. MedupeTMThato T. Medupe
- Lucy W. MachariaLMLucy W. Macharia
- Karabo SeralaKSKarabo Serala
- Mihlali V. MlazaMMMihlali V. Mlaza
- Peter OngomaPOPeter Ongoma
- Josiah O. OmoloJOJosiah O. Omolo
- Allen MambandaAMAllen Mambanda
- Sharon PrinceSPSharon Prince
- Gregory S. SmithGSGregory S. Smith
- Reinner O. OmondiROReinner O. Omondi
- 10 July 2026
- journal article
- Published by Springer Nature in Transition Metal Chemistry
- Vol. 51 (5)
Abstract
No abstract availableAll Related Versions
This publication has 62 references indexed in Scilit:
- Synthesis and Structure of Naphthoyl Thiourea‐Based Binuclear Ruthenium(II) Arene Complexes: Studies on Anticancer Activity and Apoptotic MechanismChemBioChem, 2025
- Half‐Sandwich Organometallic Ir(III) and Ru(II) Compounds and their Interactions with BiomoleculesChempluschem, 2025
- Facile Method to Obtain Functionalised η6‐Bound Arenes in Ru(II) and Os(II) Half‐Sandwich ComplexesChemistry – A European Journal, 2024
- Ru(II) and Ru(III) complexes containing N‐acylthiourea ligands: Supramolecular structures and synthons, reduction, and reaction pathway of aromatic nitro compoundsApplied Organometallic Chemistry, 2023
- Thirty Years of the Drug Candidate NAMI‐A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal PerspectiveEuropean Journal of Inorganic Chemistry, 2016
- KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor PatientsChemistry & Biodiversity, 2008
- Medicinal Organometallic Chemistry: Designing Metal Arene Complexes as Anticancer AgentsChemistry – An Asian Journal, 2008
- Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted ChemotherapyEuropean Journal of Inorganic Chemistry, 2006
- Development of organometallic (organo-transition metal) pharmaceuticalsApplied Organometallic Chemistry, 2005
- Use of Chelating Ligands to Tune the Reactive Site of Half‐Sandwich Ruthenium(II)–Arene Anticancer ComplexesChemistry – A European Journal, 2004